82 related articles for article (PubMed ID: 9725053)
1. [Serum factors in cancer patients affecting the antitumor effect of 5-fluorouracil].
Miwa M; Kojima T; Naruse T
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1591-4. PubMed ID: 9725053
[TBL] [Abstract][Full Text] [Related]
2. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
3. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
Jordan A; Stein J
Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
[TBL] [Abstract][Full Text] [Related]
4. Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro.
Blomgren H; Edler D; Hallström M; Ragnhammar P
Anticancer Res; 1996; 16(5A):2713-7. PubMed ID: 8917376
[TBL] [Abstract][Full Text] [Related]
5. [Effects of hyperthermic chemotherapy on gastrointestinal cancer cells in vitro].
Sun YM; Fu J; Zhang W; Zheng ZX; Huang CZ; Yuan XH
Ai Zheng; 2006 Aug; 25(8):974-8. PubMed ID: 16965677
[TBL] [Abstract][Full Text] [Related]
6. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
7. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
[TBL] [Abstract][Full Text] [Related]
8. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
9. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil.
Calviello G; Di Nicuolo F; Serini S; Piccioni E; Boninsegna A; Maggiano N; Ranelletti FO; Palozza P
Cancer Chemother Pharmacol; 2005 Jan; 55(1):12-20. PubMed ID: 15365767
[TBL] [Abstract][Full Text] [Related]
11. [Insulin induces anticancer cytotoxicity of 5-Fu to two human colon cancer cell lines].
Ma W; Wang LX; Wang RL; Fan QX; Lu SX
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):169-72. PubMed ID: 20450582
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
[TBL] [Abstract][Full Text] [Related]
15. [Study of in vitro cancer sensitivity of anticancer drugs by SDI (succinate dehydrogenase inhibition test)].
Kikuchi Y
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2757-62. PubMed ID: 7993111
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
17. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
[TBL] [Abstract][Full Text] [Related]
19. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A
Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326
[TBL] [Abstract][Full Text] [Related]
20. Potent antitumor effect of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine on peritoneal dissemination models of gastrointestinal cancers.
Miura S; Endo Y; Yoshimura Y; Endo M; Yonemura Y; Sasaki T
Oncol Rep; 2002; 9(6):1319-22. PubMed ID: 12375041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]